John Rublein

645 total citations
15 papers, 502 citations indexed

About

John Rublein is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, John Rublein has authored 15 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Oncology. Recurrent topics in John Rublein's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). John Rublein is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). John Rublein collaborates with scholars based in United States, United Kingdom and India. John Rublein's co-authors include Margaret A. Chesney, Cheryl Marcus, Tina Brock, Scott R. Smith, Joseph J. Eron, Angela D. M. Kashuba, Naser L. Rezk, Ralph H. Raasch, Rosa F. Yeh and Roula Qaqish and has published in prestigious journals such as AIDS, Patient Education and Counseling and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

John Rublein

14 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Rublein United States	10	296	128	117	104	66	15	502
R. Chris Rathbun United States	15	424 1.4×	172 1.3×	101 0.9×	235 2.3×	89 1.3×	35	729
Kathleen Graham United States	8	344 1.2×	189 1.5×	84 0.7×	136 1.3×	45 0.7×	12	512
Monique M. R. de Maat Netherlands	10	431 1.5×	229 1.8×	100 0.9×	118 1.1×	121 1.8×	15	606
Concepta Merry Ireland	12	303 1.0×	138 1.1×	71 0.6×	72 0.7×	110 1.7×	19	515
Salvatore Nappa Italy	10	428 1.4×	180 1.4×	210 1.8×	202 1.9×	35 0.5×	22	794
Kristin M. Darin United States	12	315 1.1×	88 0.7×	21 0.2×	104 1.0×	112 1.7×	19	475
J Ruedy Canada	13	166 0.6×	96 0.8×	20 0.2×	71 0.7×	80 1.2×	34	568
Ian R. McNicholl United States	16	604 2.0×	240 1.9×	379 3.2×	310 3.0×	135 2.0×	31	942
Ushma Mehta South Africa	19	235 0.8×	33 0.3×	24 0.2×	128 1.2×	237 3.6×	64	1.1k
Patricia W. H. Hugen Netherlands	19	973 3.3×	733 5.7×	163 1.4×	177 1.7×	172 2.6×	27	1.1k

Countries citing papers authored by John Rublein

Since Specialization

Citations

This map shows the geographic impact of John Rublein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rublein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rublein more than expected).

Fields of papers citing papers by John Rublein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Rublein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rublein. The network helps show where John Rublein may publish in the future.

Co-authorship network of co-authors of John Rublein

This figure shows the co-authorship network connecting the top 25 collaborators of John Rublein. A scholar is included among the top collaborators of John Rublein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Rublein. John Rublein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Menezes, Prema, Katie R. Mollan, Cheryl Marcus, et al.. (2018). Stable Caloric Intake and Continued Virologic Suppression for HIV-Positive Antiretroviral Treatment-Experienced Women After Switching to a Single-Tablet Regimen of Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate. AIDS Research and Human Retroviruses. 34(6). 481–485.

Rublein, John, Hsiao‐Chuan Tien, Sherene Min, et al.. (2008). Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir. American Journal of Health-System Pharmacy. 65(5). 422–428. 23 indexed citations

Yeh, Rosa F., Kristine B. Patterson, Naser L. Rezk, et al.. (2006). Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(1). 52–60. 159 indexed citations

Benson, Constance A., Charles van der Horst, Anthony LaMarca, et al.. (2004). A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. AIDS. 18(17). 2269–2276. 42 indexed citations

Klibanov, Olga M., Ralph H. Raasch, & John Rublein. (2004). Changes in renal function after changes in antifungal drug therapy. American Journal of Health-System Pharmacy. 61(1). 50–53. 3 indexed citations

Hall, Iris H., et al.. (2004). Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin. Journal of Infection and Chemotherapy. 10(1). 11–18. 2 indexed citations

Rublein, John, et al.. (2004). HIV Infection: Point-of-Care Testing. Annals of Pharmacotherapy. 38(4). 670–676. 23 indexed citations

Klibanov, Olga M., Ralph H. Raasch, & John Rublein. (2004). Single Versus Combined Antibiotic Therapy for Gram-Negative Infections. Annals of Pharmacotherapy. 38(2). 332–337. 24 indexed citations

Smith, Scott R., John Rublein, Cheryl Marcus, Tina Brock, & Margaret A. Chesney. (2003). A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling. 50(2). 187–199. 102 indexed citations

10.

Kelley, Meera, et al.. (2003). Effect of a pharmacist-managed program of pneumococcal and influenza immunization on vaccination rates among adult inpatients. American Journal of Health-System Pharmacy. 60(17). 1767–1771. 29 indexed citations

11.

Weber, David J., et al.. (2002). Treatment of Tick-Borne Diseases. Annals of Pharmacotherapy. 36(10). 1590–1597. 16 indexed citations

12.

Weber, David J., et al.. (2002). Treatment of Tick-Borne Diseases. Annals of Pharmacotherapy. 36. 1590–1597. 2 indexed citations

13.

Qaqish, Roula, et al.. (2000). HIV‐Associated Lipodystrophy Syndrome. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(1). 13–22. 64 indexed citations

14.

Rublein, John, Joseph J. Eron, John D. Butts, & Ralph H. Raasch. (1999). Discontinuation Rates for Protease Inhibitor Regimens Containing Ritonavir 600 mg versus Ritonavir 400 mg Plus Saquinavir 400 mg. Annals of Pharmacotherapy. 33(9). 899–905. 11 indexed citations

15.

Rublein, John, et al.. (1998). Letters. Journal of the American Pharmaceutical Association (1996). 38(4). 388–391. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact